1,651
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Obesity in COPD: Comorbidities with Practical Consequences?

, , , , &
Pages 464-471 | Received 04 Dec 2017, Accepted 05 Aug 2018, Published online: 04 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Ayse Dudu Altintas Dogan, Ole Hilberg, Søren Hess, Torben Tranborg Jensen, Else-Marie Bladbjerg & Claus Bogh Juhl. (2022) Respiratory Effects of Treatment with a Glucagon-Like Peptide-1 Receptor Agonist in Patients Suffering from Obesity and Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 405-414.
Read now
Suheda Ozcakir, Deniz Sigirli, Ahmet Ursavas & Esra Uzaslan. (2020) COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2441-2448.
Read now
Jing Zhu, Zhiling Zhao, Bin Wu, Zhihong Shi, Qingrong Nie, Zhen Fu, Zhaofu Zeng, Weihua Hu, Minglin Dong, Mengqing Xiong & Ke Hu. (2020) Effect of Body Mass Index on Lung Function in Chinese Patients with Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2477-2486.
Read now

Articles from other publishers (6)

Ekaterina V. Smolyakova, Yuri S. Skoblov, Natalia A. Skoblova, Anna V. Rvacheva, Olga V. Bondarets, Anna V. Eremenko, Ivan A. Kelekhsaev, Irina E. Chazova & Kirill A. Zykov. (2023) A pilot study to determine the relationship of changes in the characteristics of β1- and β2-adrenoreceptors against the background of the use of β2-agonists with clinically significant parameters in patients with cardiovascular pathology. Journal of Clinical Practice 14:1, pages 66-76.
Crossref
José Luis Lopez-Campos, Pere Almagro, José Tomás Gómez, Eusebi Chiner, Leopoldo Palacios, Carme Hernández, M. Dolores Navarro, Jesús Molina, David Rigau, Juan José Soler-Cataluña, Myriam Calle, Borja G. Cosío, Ciro Casanova & Marc Miravitlles. (2022) [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care. Archivos de Bronconeumología 58:4, pages T334-T344.
Crossref
José Luis Lopez-Campos, Pere Almagro, José Tomás Gómez, Eusebi Chiner, Leopoldo Palacios, Carme Hernández, M. Dolores Navarro, Jesús Molina, David Rigau, Juan José Soler-Cataluña, Myriam Calle, Borja G. Cosío, Ciro Casanova & Marc Miravitlles. (2022) Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos. Archivos de Bronconeumología 58:4, pages 334-344.
Crossref
Silvia Portero de la Cruz & Jesús Cebrino. (2021) Common Mental Disorders, Functional Limitation and Diet Quality Trends and Related Factors among COPD Patients in Spain, 2006–2017: Evidence from Spanish National Health Surveys. Journal of Clinical Medicine 10:11, pages 2291.
Crossref
Shannon W. FinksMark J. RumbakTimothy H. Self. (2020) Treating Hypertension in Chronic Obstructive Pulmonary Disease. New England Journal of Medicine 382:4, pages 353-363.
Crossref
Russell G. Buhr, Nicholas J. Jackson, Gerald F. Kominski, Steven M. Dubinett, Michael K. Ong & Carol M. Mangione. (2019) Comorbidity and thirty-day hospital readmission odds in chronic obstructive pulmonary disease: a comparison of the Charlson and Elixhauser comorbidity indices. BMC Health Services Research 19:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.